Sort
25,944 grants matching “neurodegeneration”
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence
$672,530John M Littleton · Naprogenix, Inc · U44 · FY2017 · AA
Function and Pathogenic Mechanism of LRRK2 in Parkinson's Disease
$672,438Huaibin Cai · National Institute On Aging · ZIA · FY2011 · AG
Characterizing Persistent Subclinical Neurobehavioral Effects of COVID-19 in a Diverse Urban Population
$672,352Johanna Patricia Daily · Albert Einstein College Of Medicine · R01 · FY2024 · NS
PATHOLOG-OMICS - ESSENTIAL TREMOR IN THE BROADER CONTEXT OF NEURODEGENERATION
$671,911Elan D Louis · Yale University · R01 · FY2018 · NS
Urate as a Predictor of Parkinson's Disease Risk and Progression
$671,891Alberto Ascherio · Harvard School Of Public Health · R01 · FY2011 · NS
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases
$671,753Pembe Hande Ozdinler · Northwestern University At Chicago · R01 · FY2019 · AG
Targeting specific MicroRNA to alleviate Alzheimerâs Disease pathobiology
$671,739Amal O Amer · Ohio State University · R01 · FY2025 · AG
Modeling and Pathological Study of Sporadic Parkinson's Disease
$671,654Huaibin Cai · National Institute On Aging · ZIA · FY2017 · AG
In Vivo Function and Metabolism Evaluation of Glaucomatous RGCs by Two-Photon Scanning Laser Ophthalmology
$671,615Yang Hu · Stanford University · R01 · FY2024 · EY
Risk for Severe/Profound Intellectual Disability in Down Syndrome
$671,521Deborah J Fidler · Colorado State University · R01 · FY2025 · HD
Genetic Basis of Failed Cognition in Young and Aged Mouse Models of Trisomy 21
$671,481William C Mobley · University Of California, San Diego · R01 · FY2010 · NS
Nitric Oxide-Soluble Guanylate Cyclase Pathway as a Target for Male Bladder Outlet Obstruction and Lower Urinary Tract Symptoms in Aging
$671,019Anthony John Kanai · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DK
Pathways of HIV neurodegeneration and dimethyl fumarate (DMF/MMF) neuroprotection
$670,774Dennis Larry Kolson · University Of Pennsylvania · R01 · FY2015 · MH
The role of microglia in Parkinson's disease cognitive and motor impairment
$670,600Kelly Alexander Mills · Johns Hopkins University · R01 · FY2025 · NS
Endolysosomal trafficking and lipid metabolism defects in FTLD
$670,577Eric J Huang · University Of California, San Francisco · R01 · FY2024 · AG
Endolysosomal trafficking and lipid metabolism defects in FTLD
$670,577Eric J Huang · University Of California, San Francisco · R01 · FY2023 · AG
Structure, Biosynthesis & Function of Glycoproteins
$670,528Stuart A Kornfeld · Washington University · R37 · FY2016 · CA
Enhancement of Brain Dysfunction in Sepsis Survivors by Alzheimerâs Disease Neuropathology
$670,518Benjamin Herschel Singer · University Of Michigan At Ann Arbor · R01 · FY2024 · AG
LRRK in Autophagy Function and Dopaminergic Neuron Survival
$670,490Jie Shen · Brigham And Women'S Hospital · R37 · FY2019 · NS
LRRK in Autophagy Function and Dopaminergic Neuron Survival
$670,490Jie Shen · Brigham And Women'S Hospital · R37 · FY2021 · NS
LRRK in Autophagy Function and Dopaminergic Neuron Survival
$670,490Jie Shen · Brigham And Women'S Hospital · R37 · FY2020 · NS
Advanced glycation endproducts (AGEs) as metabolic by-products that mediate neurodegeneration.
$670,411Pankaj Kapahi · Buck Institute For Research On Aging · R01 · FY2019 · AG
Epigenetic-Genetic Modulations in Aging and Alzheimer's Disease Neurons
$670,000Evgeny I Rogaev · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · AG
Genetically Encoded Probes of Huntingtin Misfolding
$669,687Ralf Langen · University Of Southern California · R01 · FY2022 · NS
Endolysosomal trafficking and lipid metabolism defects in FTLD
$669,477Eric J Huang · Washington University · R01 · FY2025 · AG